Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tacrolimus to Sirolimus Conversion for Delayed Graft Function (RAPA)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by University of Maryland.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
University of Maryland
ClinicalTrials.gov Identifier:
NCT00931255
First received: June 29, 2009
Last updated: December 14, 2009
Last verified: December 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2012
  Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)